Clinical Trial Update: Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of omalizumab for severe Japanese cedar pollinosis (seasonal allergic rhinitis) in adults and adolescents has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Cedar Pollinosis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2019-11-04